CLINICAL_TRIALS
trial_result
· 2016-05-12
Clinical Trial Update: Kuvan® in Phenylketonuria Patients Less Than 4 Years Old [Phase 3]
Summary
Phase 3 trial update for Kuvan in phenylketonuria patients under 4 years old; study completed with results posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: BioMarin Pharmaceutical | Conditions: Phenylketonuria | Phase 3 | Status: COMPLETED | Results posted: 2016-05-12